Mechanistically, TRIB2-PCBP2 interaction leads to a decrease in the ubiquitin pool by increasing the proteolytic efficiency of the proteasome and, consequently, maintains the viability of the liver cancer cells and promotes tumour growth [48]. Here, TRIB2 is linked to liver cancer.